Elsevier

Clinical pathways provide evidence-based treatment guidance that supports standardization of care. In a roundtable and webinar, sponsored by Elsevier's ClinicalPath, oncology leaders and pathway experts discussed the benefits and appropriate use of clinical pathways in oncology. This report presents valuable insights from those discussions.  

Healthcare institutions struggle to reduce unwarranted care variation. Learn how to keep pace with clinical knowledge growth by supplementing in-house tools with commercially developed pathways.

The obstacles to personalized medicine include the high cost of precision cancer drugs, the challenge of getting patients fully engaged in their own care, a lack of mature, universal interoperability, and questions about the effectiveness of precision medicine interventions. This presentation will address these issues and discuss how to mainstream the benefits of precision medicine to institutions large and small.